Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease.
Autor: | Meng-Ting Wang1 wmt@mail.ndmctsgh.edu.tw, Jyun-Heng Lai1 terry820426@gmail.com, Chen-Liang Tsai2 doc10376@ndmctsgh.edu.tw, Jun-Ting Liou3 ljtmail@gmail.com |
---|---|
Zdroj: | Journal of Food & Drug Analysis. Jul2019, Vol. 27 Issue 3, p657-670. 14p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |